CD44 and neoplasm: Analysis of metastatic CRC samples from peritoneal washings and comparison to the CRC tumor cell line HCT116 by Botchkina et al., identified similar CD133+ and CD44+/CD166+/EpCAMHigh cell populations with tumorigenic potential similar to prior studies [66,67].